ImmuCell
ICCC
27 hedge funds and large institutions have $3.88M invested in ImmuCell in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
22% more capital invested
Capital invested by funds: $3.17M → $3.88M (+$711K)
13% more funds holding
Funds holding: 24 → 27 (+3)
0.6% more ownership
Funds ownership: 9.31% → 9.91% (+0.6%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFS
Essex Financial Services
Essex,
Connecticut
|
+$111K |
| 2 |
Renaissance Technologies
New York
|
+$102K |
| 3 |
Mercer Global Advisors
Denver,
Colorado
|
+$62.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$10.1K |
| 2 |
BlackRock
New York
|
-$9.1K |
| 3 |
Morgan Stanley
New York
|
-$8.27K |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$7K |
| 5 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$2.16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$17 | -3 | -9% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$488 | +88 | New |
|
ICCC Hedge Fund Activity: Q3 2020 in Review
27 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2020, worth a combined $3.88M — up 22% from $3.17M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ICCC positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Essex Financial Services, opening a new position worth an estimated $111K. The largest seller was Northern Trust, cutting an estimated $10.1K.
- 27 institutional investors held ImmuCell (ICCC) as of Q3 2020, up from 24 in Q2 2020.
- Funds reported $3.88M of ImmuCell stock for Q3 2020, up 22% quarter-over-quarter.
- 4 funds opened new ImmuCell positions in Q3 2020 and 1 closed out, a net change of +3 holders.
- The largest ImmuCell buyer in Q3 2020 was Essex Financial Services, an estimated $111K added.
- The largest ImmuCell seller in Q3 2020 was Northern Trust, an estimated $10.1K sold.
Based on aggregated 13F filings for Q3 2020.